SCHEMBL17952

SCHEMBL17952

CCCNC[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.69
GCKR Q14397 8/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12077796 0.91 GCKR (0.75) GCKGCKR
SCHEMBL17023 0.90 GCKR (0.66) GCKGCKR
SCHEMBL17475 0.90 GCK (0.69) GCKGCKR
SCHEMBL17728 0.90 GCK (0.73) GCKGCKR
SCHEMBL18183 0.89 GCKR (0.72) GCKGCKR
SCHEMBL18204 0.89 GCK (0.74) GCKGCKR
SCHEMBL18320 0.89 GCK (0.74) GCKGCKR
SCHEMBL16826 0.88 GCKR (0.68) GCKGCKR
SCHEMBL17399 0.88 GCK (0.71) GCKGCKR
SCHEMBL15202921 0.88 GCK (0.71) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed